Slider
Deustropin 4/12 product pack
Deus Medical logo

DEUSTROPIN 4/12 (Recombinant Human Growth Hormone [rDNA origin])

• CAS number: 12629-01-5
• Molecular Weight: 22.260 kDa
• Formula: C990H1529N263O299S7

Authenticity protected scan our product QR code

DEUSTROPIN 4/12 by DEUS MEDICAL®

DEUSTROPIN 4/12 (Recombinant Human Growth Hormone [rDNA origin])

Deustropin 4/12 product pack

Overview

DEUSTROPIN 4/12 (Recombinant Human Growth Hormone [rDNA origin]) is a growth hormone analog that is used to treat children with growth hormone deficiency. It is a polypeptide hormone that has recombinant DNA origin.

DEUSTROPIN 4/12 Mechanism of Action

DEUSTROPIN 4/12 is a recombinant growth hormone that acts on bone, cartilage, and muscle to stimulate growth in childhood. It acts just like the natural growth hormone. It can be used to treat both children and adults with growth hormone deficiency. It increases the concentration of Insulin-Like Growth Factor-1  (IGF-1) which plays a role in skeletal growth. It also increases the synthesis of protein and increases the lean body mass. 

DEUSTROPIN 4/12 Dosage

Weight-based dosing as directed by a physician.

DEUSTROPIN 4/12 Side effects

Headache nausea, fatigue, vomiting. weakness, eye problems, irregular heartbeats slurred speech, joint stiffness and impaired glucose tolerance.

DEUSTROPIN 4/12 Interactions

Oral hypoglycemic drugs, steroids cyclosporine, oral contraceptive, macimorelin.

Composition

? Recombinant Human Growth Hormone [rDNA origin] . . . 4mg
? Excipients . . . . . . . . . . . . . . . . . . . . . q.s

Deustropin 4/12 back of the product pack
Authenticity protected scan our product QR code

BECOME A PARTNER

We are offering a diverse range of pharmaceutical products, which are available only from an authorized resellers. Our highly-regarded partners are comprised of industry experts who share our values and commitment. Our goal is to strengthen our network of prestigious professionals who strive to deliver great quality products.
We believe that partnerships are essential to drive change, innovation and transformation, and we are committed to ensuring the success of our collaborations.